Download PDF
Thromb Haemost 1979; 41(04): 718-733
DOI: 10.1055/s-0038-1646832
Original Articles
Schattauer GmbH Stuttgart

Separation of Plasminogen Activators from Human Uterine Tissue and a Comparison with Activators from Human Urine and Porcine Tissue

Preben Kok
The Department of Medical Chemistry, University of Umeå, S-901 87 Umeå, Sweden
› Author Affiliations
Further Information

Publication History

Received30 June 1978

Accepted 10 August 1978

Publication Date:
09 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Three types of plasminogen activator could be distinguished in extracts from human uterine tissue. The activators differed in thermostability or in mode of inhibition by EACA.

All the extracts contained stable as well as labile activators. The saline extracts were uniformly inhibited by increasing concentrations of EACA. Extracts made with 2 M ammonium thiocyanate were either uniformly inhibited by EACA or showed deflections indicating contamination with an activator, which was inhibited in a biphasic manner. It was possible to distinguish between: (1) An activator, abundantly present in the tissue, which was uniformly inhibited and stable. (2) Another uniformly inhibited activator, which was labile. (3) An activator, inhibited in a biphasic manner, similar to urokinase, which was present in varying amounts in uteri with the endometrium in the proliferative phase.

Gel filtration of the uterine extracts showed two major activity peaks corresponding to particle sizes of 60,000 dalton and about 10,000 dalton.

Antiserum to purified plasminogen activator, prepared from porcine ovaries, inhibited the activity of the human uterine extracts, but not the activities of human urokinase or urine. Urokinase antiserum in a concentration completely inhibiting human urine or urokinase, inhibited only 10% or less of the activities of human uterine extracts.

 

  • References

  • 1 Albrechtsen OK. 1956; The fibrinolytic activity of the human endometrium. Acta Endocrinologica 23: 207
    PubMedSearch in Google Scholar
  • 2 Albrechtsen OK. 1958; The fibrinolytic agents in saline extracts of human tissues. The Scandinavian Journal of Clinical and Laboratory Investigation 10: 91
    PubMedSearch in Google Scholar
  • 3 Aoki N, von Kaulla KN. 1971; The extraction of vascular plasminogen activator from human cadavers and a description of some of its properties. American Journal of Clinical Pathology 55: 171
    CrossrefPubMedSearch in Google Scholar
  • 4 Åstedt B, Holmberg L. 1976; Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture. Nature 261: 595
    CrossrefPubMedSearch in Google Scholar
  • 5 Astrup T. 1966; Tissue activators of plasminogen. Federation Proceedings 25: 42
    PubMedSearch in Google Scholar
  • 6 Astrup T, Albrechtsen OK. 1957; Estimation of the plasminogen activator and the trypsin inhibitor in animal and human tissues. The Scandinavian Journal of Clinical and Laboratory Investigation 9: 233
    PubMedSearch in Google Scholar
  • 7 Astrup T, Kok P. 1970; Assay and preparation of a tissue plasminogen activator. Methods in Enzymology 19: 821
    PubMedSearch in Google Scholar
  • 8 Astrup T, Mullertz S. 1952; The fibrin plate method for estimating fibrinolytic activity. Archives of Biochemistry and Biophysics 40: 346
    CrossrefPubMedSearch in Google Scholar
  • 9 Astrup T, Thorsen S. 1972; The physiology of fibrinolysis. Medical Clinics of North America 56: 153
    CrossrefPubMedSearch in Google Scholar
  • 10 Bernik MB, Kwaan HC. 1969; Plasminogen activator activity in cultures from human tissue. An immunological and histochemical study. The Journal of Clinical Investigation 48: 1740
    CrossrefPubMedSearch in Google Scholar
  • 11 Bernik MB, White WF, Oller EP, Kwaan HC. 1974; Immunological identity of plasminogen activator in human urine, heart, blood vessels, and tissue culture. Journal of Laboratory and Clinical Medicine 84: 546
    PubMedSearch in Google Scholar
  • 12 Brakman P. 1965; Bovine fibrinogen without detectable plasminogen. Analytical Biochemistry 11: 149
    CrossrefPubMedSearch in Google Scholar
  • 13 Brakman P. 1967. Fibrinolysis. A standardized fibrin plate method and a fibrinolytic assay of plasminogen.. Scheltema and Holkema; Amsterdam:
    Search in Google Scholar
  • 14 Christman JK, Acs G. 1974; Purification and characterization of a cellular fibrinolytic factor associated with oncogenic transformation: the plasminogen activator from SV 40 transformed hamster cells. Biochemica Biophysica Acta 340: 339
    PubMedSearch in Google Scholar
  • 15 Christman JK, Silverstein SC, Acs G. 1975; Immunological analysis of plasminogen activators from normal and transformed hamster cells. Evidence that the plasminogen activators produced by SV 40 virus-transformed hamster embryo cells and normal hamster lung cells are antigenically identical. The Journal of Experimental Medicine 142: 419
    CrossrefPubMedSearch in Google Scholar
  • 16 Doleschel W. 1975; Isolierung einer dritten humanen Urokinase (S0-Type). Wienerklinische Wochenschrift 87: 282
    PubMedSearch in Google Scholar
  • 17 Kok P, Astrup T. 1967; Some comparative studies on tissue activator and urokinase. Thrombosis et Diathesis Haemorrhagica 18: 294
    PubMedSearch in Google Scholar
  • 18 Kok P, Astrup T. 1969; a Isolation and purification of a tissue plasminogen activator and its comparison with urokinase. Biochemistry. 8: 79
    PubMedSearch in Google Scholar
  • 19 Kok P, Astrup T. 1969; b Distinction of human tissue plasminogen activator from human urokinase with e-aminocaproic acid (EACA). Federation Proceedings 28: 441 Abstract
    PubMedSearch in Google Scholar
  • 20 Kok P, Astrup T. 1972; a Differentiation between plasminogen activators by means of epsilon- aminocaproic acid. Thrombosis et Diathesis Haemorrhagica 27: 11
    PubMedSearch in Google Scholar
  • 21 Kok P. 1972. b Demonstration of different types of plasminogen activators in human tissue and a comparison with activators in urine and blood. Third Congress on Thrombosis; Washington D. C.: 22.08.1972. Abstracts p. 300
    Search in Google Scholar
  • 22 Kucinski CS, Fletcher AP, Sherry S. 1968; Effect of urokinase antiserum on plasminogen activators: Demonstration of immunologic dissimilarity between plasma plasminogen activator and urokinase. Journal of Clinical Investigation 47: 1238
    CrossrefPubMedSearch in Google Scholar
  • 23 Page EW, Glendening MB, Parkinson D. 1951; Cyclic biochemical changes in the human endometrium with special reference to the fibrinolytic enzyme. American Journal of Obstetrics and Gynecology 62: 1100
    CrossrefPubMedSearch in Google Scholar
  • 24 Pugath EM F, Poole JC F. 1969; Studies on the fibrinolytic activity of an extract from vascular endothelium. Quarterly Journal of Experimental Physiology 54: 80
    CrossrefPubMedSearch in Google Scholar
  • 25 Siew C, Celander E. 1968; Plasmin activator in the cytoplasmic granules of bovine jugular vein endothelium. Enzymologia Biologica et Clinica 9: 459
    CrossrefPubMedSearch in Google Scholar
  • 26 Thorsen S, Astrup T. 1969; Biphasic inhibition of urokinase-induced fibrinolysis by e- aminocaproic acid; distinction from tissue plasminogen activator. Proceedings of the Society for Experimental Biology and Medicine 130: 811
    PubMedSearch in Google Scholar
  • 27 Thorsen S, Kok P, Astrup T. 1974; Reversible and irreversible alterations of human plasminogen indicated by changes in susceptibility to plasminogen activators and in response to e- aminocaproic acid. Thrombosis et Diathesis Haemorrhagica 32: 325
    PubMedSearch in Google Scholar
  • 28 Wallén P, Wiman B. 1975. On the generation of intermediate plasminogen and its significance for activation. Proteases and Biological Control. p. 291 Cold Spring Harbor Laboratory; U.S.A:
    Search in Google Scholar